Kt International Investment Limited - Net Worth and Insider Trading
Kt International Investment Limited Net Worth
The estimated net worth of Kt International Investment Limited is at least $46 Million dollars as of 2024-11-07. Kt International Investment Limited is the 2101 Beneficial owner of Kintor Pharmaceutical Ltd and owns about 41,004,770 shares of Kintor Pharmaceutical Ltd (HKSE:09939) stock worth over $46 Million. Details can be seen in Kt International Investment Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kt International Investment Limited has not made any transactions after 2023-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kt International Investment Limited
Kt International Investment Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kt International Investment Limited owns 1 companies in total, including Kintor Pharmaceutical Ltd (HKSE:09939) .
Insider Ownership Summary of Kt International Investment Limited
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:09939 | Kintor Pharmaceutical Ltd | 2023-12-19 | 2101 Beneficial owner |
Kt International Investment Limited Latest Holdings Summary
Kt International Investment Limited currently owns a total of 1 stock. Kt International Investment Limited owns 41,004,770 shares of Kintor Pharmaceutical Ltd (HKSE:09939) as of December 19, 2023, with a value of $46 Million.
Latest Holdings of Kt International Investment Limited
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:09939 | Kintor Pharmaceutical Ltd | 2023-12-19 | 41,004,770 | 1.13 | 46,335,390 |
Holding Weightings of Kt International Investment Limited
Kt International Investment Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Kt International Investment Limited has made a total of 6 transactions in Kintor Pharmaceutical Ltd (HKSE:09939) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kintor Pharmaceutical Ltd is the acquisition of 500,000 shares on December 19, 2023, which cost Kt International Investment Limited around $773,750.
Insider Trading History of Kt International Investment Limited
- 1
Kt International Investment Limited Trading Performance
GuruFocus tracks the stock performance after each of Kt International Investment Limited's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kt International Investment Limited is -36.36%. GuruFocus also compares Kt International Investment Limited's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kt International Investment Limited within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kt International Investment Limited's insider trading performs compared to the benchmark.
Performance of Kt International Investment Limited
Kt International Investment Limited Ownership Network
Ownership Network List of Kt International Investment Limited
Ownership Network Relation of Kt International Investment Limited
Kt International Investment Limited Owned Company Details
What does Kintor Pharmaceutical Ltd do?
Who are the key executives at Kintor Pharmaceutical Ltd?
Kt International Investment Limited is the 2101 Beneficial owner of Kintor Pharmaceutical Ltd. Other key executives at Kintor Pharmaceutical Ltd include 2101 Beneficial owner Tong Youzhi , 2201 Interest of corporation controlled by you Guo Chuangxing , and 2101 Beneficial owner Kg Development Limited .
Kintor Pharmaceutical Ltd (HKSE:09939) Insider Trades Summary
Over the past 18 months, Kt International Investment Limited made 1 insider transaction in Kintor Pharmaceutical Ltd (HKSE:09939) with a net purchase of 500,000. Other recent insider transactions involving Kintor Pharmaceutical Ltd (HKSE:09939) include a net sale of 0 shares made by Nomura Holdings, Inc. , a net sale of 10,429,971 shares made by Kg Development Limited , and a net sale of 10,429,971 shares made by Guo Chuangxing .
In summary, during the past 3 months, insiders sold 0 shares of Kintor Pharmaceutical Ltd (HKSE:09939) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,000,000 shares of Kintor Pharmaceutical Ltd (HKSE:09939) were sold and 2,140,058 shares were bought by its insiders, resulting in a net sale of 19,859,942 shares.
Kintor Pharmaceutical Ltd (HKSE:09939)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintor Pharmaceutical Ltd Insider Transactions
Kt International Investment Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Kt International Investment Limited. Currently GuruFocus does not have mailing address information for Kt International Investment Limited.